Repository logo
 
Loading...
Thumbnail Image
Publication

Evaluation of cystamine-modified hyaluronic acid/chitosan polyplex as retinal gene vector

Use this identifier to reference this record.

Advisor(s)

Abstract(s)

A successful gene therapy approach can prevent or treat congenital and acquired diseases. However, there is still no ideal non-viral vector for gene delivery in a safe and timely manner. In this report the anionic polymer hyaluronic acid (HA) was investigated as a potential vector for gene therapy. Due to its intrinsic characteristics it constitutes an excellent candidate to deliver therapeutic genes, pending the modification of its surface charge.

Description

Keywords

Gene therapy Hyaluronic acid Polymer modification Retina Biocompatibility

Citation

Mater. Sci. Eng. C, 58, 2016, 264–272

Organizational Units

Journal Issue